Innate Pharma S.A. Anteile 2011-2026 | IPHA

Anteile Jährlich Innate Pharma S.A.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	79.5 M	66.9 M	66.9 M	-	-	-	-	-	-	-	-

Alle Zahlen in EUR-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
79.5 M	66.9 M	71.1 M

Anteile anderer Aktien in der Pharmaeinzelhändler

Name	Anteile	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	33.4 M	-	2.43 %	$ 254 M	Germany
Aligos Therapeutics ALGS	9.88 M	$ 8.64	8.07 %	$ 85.4 M	USA
Alterity Therapeutics Limited ATHE	2.41 B	$ 3.66	-1.48 %	$ 8.81 B	Australia
I-Mab IMAB	220 M	-	-	$ 866 M	China
AlloVir ALVR	15.3 M	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	38.8 M	-	-	$ 10.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	219 M	-	-	$ 40.3 B	USA
Genfit SA GNFT	44.7 B	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	118 M	-	-13.47 %	$ 169 M	France
Applied Therapeutics APLT	84.2 M	-	-	$ 8.42 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	4.58 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	80.5 M	-	-18.52 %	$ 27.3 M	Britain
Amphastar Pharmaceuticals AMPH	46.7 M	$ 21.36	4.86 %	$ 998 M	USA
Acorda Therapeutics ACOR	1.24 M	-	-24.86 %	$ 820 K	USA
Институт стволовых клеток человека ISKJ	75 M	-	-	-	Russia
Adverum Biotechnologies ADVM	19.8 M	-	-	$ 86.2 M	USA
Advaxis ADXS	6.02 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	115 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	10.2 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	78.2 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	257 M	$ 1.47	5.0 %	$ 378 M	USA
Applied Genetic Technologies Corporation AGTC	45 M	-	-	$ 26.5 M	USA
Allakos ALLK	86.8 M	-	-	$ 28.6 M	USA
Aptinyx APTX	67.7 M	-	-39.0 %	$ 4.57 M	USA
Can-Fite BioPharma Ltd. CANF	1.65 M	$ 2.92	-	$ 4.81 M	Israel
Aquestive Therapeutics AQST	107 M	$ 4.19	2.7 %	$ 448 M	USA
Aravive ARAV	36.4 M	-	-13.39 %	$ 1.45 M	USA
Arcutis Biotherapeutics ARQT	127 M	$ 24.12	-0.37 %	$ 3.07 B	USA
AIkido Pharma AIKI	14.3 M	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	66.4 M	$ 32.59	1.09 %	$ 2.16 B	USA
Autolus Therapeutics plc AUTL	266 M	$ 1.47	-1.34 %	$ 391 M	Britain
Aptose Biosciences APTO	2.45 M	-	-45.71 %	$ 1.2 M	Canada
Cidara Therapeutics CDTX	6.35 M	-	-	$ 1.41 B	USA
AVROBIO AVRO	44.3 M	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	15.4 M	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	1.42 B	-	-	$ 96.9 B	Britain
Akero Therapeutics AKRO	67.1 M	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	186 M	-	-	$ 867 M	Germany
Brainstorm Cell Therapeutics BCLI	9.27 M	-	-2.5 %	$ 5.88 M	USA
BeiGene, Ltd. BGNE	1.42 B	-	0.49 %	$ 251 B	Cayman-islands
Akouos AKUS	34.4 M	-	0.23 %	$ 488 M	USA
Akari Therapeutics, Plc AKTX	67.3 B	$ 4.25	8.35 %	$ 286 B	Britain
Allena Pharmaceuticals ALNA	68 M	-	3.16 %	$ 1.9 M	USA
Esperion Therapeutics ESPR	208 M	$ 2.22	2.3 %	$ 461 M	USA
Evogene Ltd. EVGN	40.4 M	$ 0.82	1.13 %	$ 27.9 M	Israel
Baudax Bio BXRX	332 K	-	0.59 %	$ 63 K	USA
Cabaletta Bio CABA	100 M	$ 3.2	2.24 %	$ 322 M	USA
Alpine Immune Sciences ALPN	33.4 M	-	-	$ 2.17 B	USA
CymaBay Therapeutics CBAY	106 M	-	-	$ 3.45 B	USA
Aileron Therapeutics ALRN	25.4 M	-	10.36 %	$ 9.8 M	USA